Nemolizumab Beats Placebo for Reduction of Pruritus in Eczema

THURSDAY, July 9, 2020 -- For patients with atopic dermatitis and moderate-to-severe pruritus, nemolizumab results in a greater reduction in pruritus than placebo, according to a study published in the July 9 issue of the New England Journal of...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news